Who we are

Emma has over 7 years of experience in life science consulting, partnering with local, regional, and global brand teams to optimise strategies that enhance market position and accelerate growth. She has a strong understanding of multiple therapeutic areas, particularly within I&I, and works across the product lifecycle, with specific expertise in competitive simulations, launch strategy, and lifecycle management.

Vincent has over 7 years of experience in life sciences strategy and specialises in commercial development from early-stage opportunity assessments through product launch planning, competitive war gaming, and lifecycle management. Vincent excels in facilitating cross-functional workshops and strategic planning sessions that help clients make strategic choices and drive impactful action around critical decisions.

Frances has 8+ years of experience across life science consulting and insights, with expertise in vaccines, cardiovascular, and immunology. During her time at Osprey Health she has led engagements spanning market assessment, launch planning, and brand strategy. Frances takes great pride in fostering thought-partner relationships with clients and collaborating to solve complex problems.

With over 5 years of experience within pharma and strategic consulting, Louise is passionate about driving impactful change in healthcare. As a strategic consultant, Louise has developed expertise across diverse therapeutic areas, including oncology, cardiovascular, and infectious diseases, and has successfully led global, regional, and local strategic planning projects.

Megha has expertise supporting clients through critical business decisions and brings valuable experience from her time as a Brand Manager. With a focus on competitor simulations, Megha helps clients anticipate shifts in the competitive landscape and equips them with strategies to stay ahead. Megha holds a PhD in Biochemistry from the University of Southampton and an MSci in Biochemistry from the University of Birmingham.

Olivia has extensive experience across a diverse range of therapeutic areas and markets. She is focused on brand and launch planning, helping clients optimise strategies to maximise impact. She holds an MPhil in Bioscience Enterprise from the University of Cambridge, and a BSc in Chemistry from the University of Nottingham.

Eleni has expertise in brand and launch planning, competitive strategy, and scenario planning. She has contributed to projects across a wide range of therapeutic areas, through her work at Osprey and prior experience in competitive intelligence. Eleni completed a post-doctoral fellowship in Type 2 Diabetes at Imperial College London and earned her Ph.D. in medicine from the University of Southampton.

Will has broad experience across brand strategy, competitor simulations, and launch planning. He has a keen interest in rare disease and immunology, cultivated through his work at Osprey and prior experience as a CI analyst. Will holds an MSc in Management from Henley Business School, where he studied the strategic and operational challenges facing multinational companies today.

Matt has broad experience across pharma consulting, brand strategy, and analysis. He teams with cross‑functional leadership teams to make confident decisions, focusing on brand and portfolio strategy, competitive management, and launch strategy across Oncology and Immunology. Working globally, he clarifies choices and supports teams in translating strategy into targeted action that delivers measurable impact.

Fani has a strong background in brand strategy, competitor simulation, and launch planning across various therapeutic areas, with 10+ years of experience across consulting and basic & translational biology within the highly competitive academic sector. She possesses an in-depth understanding of cellular functions and their implications in disease development. Fani holds a PhD in Biophysics from King’s College London.

Helin has experience in launch planning, brand strategy, and competitive intelligence to support strategic decision-making. Helin has a strong interest in immunology, vaccines, and gene therapies, developed through her PhD in Molecular Virology from King’s College London.

Jo has over 7 years of experience in life science consulting and customer insights, with a strong background across a range of therapeutic areas including CRM, oncology, rare disease, and neurology. She has a depth of familiarity with a range of strategic planning processes across the product lifecycle, including product launch strategy, competitive management, and brand strategy.

Sophie has a wealth of experience across a wide range of strategic planning projects in various therapeutic areas, including launch & brand planning, competitive strategy development, and supporting the execution of scientific community engagements. This experience has been developed across women’s health, oncology, respiratory diseases, infectious diseases, and rare diseases at a global, regional, and national level.

Louise brings 5+ years of experience in life science consulting and insights, combining broad cross-therapy expertise with a genuine passion for improving patient outcomes. Her work spans the entire product lifecycle, and she has supported teams globally to sharpen strategy, strengthen collaboration, and evolve ways of working. She holds a BSc in Biomedical Sciences with Intercalated Year Abroad from the University of Warwick.

Ruggiero holds a degree in Medicine and applies a clinically grounded perspective to strategic consulting in the pharmaceutical sector. His broad experience spans brand strategy, launch planning, and competitive decision-making across oncology, immunology, rare diseases, and vaccines.

Stelios brings a PhD in Chemical Biology and over five years’ experience across start-ups, research, and consulting to his work in pharma strategy. He has supported clients in oncology, rare diseases, and tendering, delivering insights that inform competitive strategy and decision-making.

Will brings experience in life science consulting and insights, supporting product launches and brand strategy across a broad range of therapeutic areas including oncology, cardiovascular, and nephrology. He holds a BSc in Biology from the University of Bath with a placement year in analytical development at a global pharmaceutical CDMO.

Kalina brings extensive experience in strategic consulting, spanning product launch planning, brand strategy, and competitive management across disease areas, with a focus on immunology, oncology, and vaccines. She works with global and regional teams to support them in turning strategy into actionable plans, applying a creative, visual-thinking approach to maximise impact. She holds an MRes in Bioengineering, Imperial College London.

Eloise has experience partnering with global and regional teams to support product launches and provide strategic competitor insights across immunology, rare diseases, and vaccinology. She holds a DPhil in immunology from the University of Oxford.

Szilvia has over 10 years of secretarial and office management experience. She has a strong background in business finance, event management, leadership support, and HR. Szilvia actively seeks new challenges, embraces additional responsibilities, and is highly adaptive. She is recognised for her punctuality, efficiency, and strong dedication to continuous learning and personal growth.